Companies eHealth, Inc.
eHealth (EHTH): executive pay, fiscal 2025
Free brief. Every figure links to the company’s own filing.
Velarion Intel: free for 3 days, no card →Email me eHealth, Inc.’s executive pay brief as a PDF
You get it on this page the moment you ask, and a copy by email. Every figure is cited to its filing.
After the PDF, up to three short notes on the deeper reports for this company. Reply “unsubscribe” to any of them, any time.
CEO vs. named peers28th pct.Of 23 peer CEOs
CEO pay, last three years
- $3,262,665FY2025
CEO total pay was $3,262,665 in fiscal 2025; the brief holds no earlier figure for this CEO.
FY2025: salary $290,769 · bonus $600,000 · stock awards $1,956,000 · option awards $0
Executives and directors
Derrick Duke · CEOMichelle Barbeau · Chief Revenue OfficerFrancis Soistman · Chief Executive OfficerJohn Dolan · CFOA. John Hass, III · Independent DirectorAaron C. Tolson · Former director (through FY2025)Andrea C. Brimmer · Independent DirectorBeth A. Brooke · Chair of the BoardCesar M. Soriano · Independent DirectorDale B. Wolf · Independent DirectorErin L. Russell · Independent DirectorPrama Bhatt · Independent DirectorTodd Arden · Independent Director
Frequently asked questions
Who was the highest-paid executive at eHealth, Inc. in fiscal 2025?
As disclosed, Derrick Duke (Chief Executive Officer) was the highest-paid executive at eHealth, Inc. in fiscal 2025, with total compensation of $3,262,665.
How does eHealth, Inc.'s chief executive pay compare to its disclosed peer group?
As disclosed, Derrick Duke's total compensation ranked at the 28th percentile of eHealth, Inc.'s disclosed peer group.
How did shareholders vote on eHealth, Inc.'s executive compensation?
As disclosed, 92.97% of shareholders supported eHealth, Inc.'s executive compensation in the latest say-on-pay vote.
How much does eHealth, Inc. spend in total on board compensation for fiscal 2025?
As disclosed, eHealth, Inc. reported total board compensation of $1,959,740 for fiscal 2025.
Answers are drawn only from the figures disclosed in this brief and cited to their location in the source filing. Where a figure required for an answer is not disclosed, that is stated rather than estimated.
Full detail
Every table from the filing. Open any section.
Summary compensation table
| Named executive officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|
| Derrick Duke | $290,769 | $600,000 | $1,956,000 | $0 | $414,247 | $0 | $1,649 | $3,262,665 |
| Chief Executive Officer | ||||||||
| Francis Soistman | 748,269 | 1,000,000 | 0 | 0 | 1,080,000 | 0 | 16,910 | 2,845,179 |
| Former Chief Executive Officer | ||||||||
| John Dolan | 441,692 | 0 | 353,150 | 0 | 421,000 | 0 | 12,882 | 1,228,724 |
| Senior Vice President, Chief Financial Officer | ||||||||
| Michelle Barbeau | 431,654 | 0 | 353,150 | 0 | 387,000 | 0 | 11,363 | 1,183,167 |
| Chief Revenue Officer | ||||||||
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.
Three-year trend — total compensation per named executive
| Named executive officer | FY2025 total | FY2024 total | FY2023 total | Δ FY2024→2025 |
|---|---|---|---|---|
| Derrick Duke | $3,262,665 | — | — | — |
| Francis Soistman | 2,845,179 | 3,428,203 | 4,994,258 | ↓ −583,024 |
| John Dolan | 1,228,724 | — | — | — |
| Michelle Barbeau | 1,183,167 | 1,923,692 | — | ↓ −740,525 |
Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.
Incentive-plan design — the Compensation Discussion & Analysis
eHealth strives to balance the need to compete for executive talent with maintaining a reasonable and responsible cost structure, while promoting closer alignment of executive officers' interests with stockholders' interests. The Company designs executive compensation programs to provide the majority of compensation in the form of variable, at-risk pay earned based on performance, with pay directly linked to performance and an emphasis on creating sustainable, profitable growth and long-term stockholder value. The Compensation Committee exercises judgment to establish a total compensation mix of current, short- and long-term incentive compensation and cash and non-cash compensation appropriate to achieve corporate objectives.
| CEO STI target (% of salary) | — |
|---|---|
| CEO LTI target (% of salary) | — |
| Independent consultant | Aon |
| Clawback policy | true |
| Anti-hedging | true |
| Anti-pledging | True |
Equity grants and outstanding awards
Grants of plan-based awards — fiscal year 2025
| Executive | Award | Grant date | Threshold | Target | Granted | Maximum | Grant-date fair value |
|---|---|---|---|---|---|---|---|
| Michelle Barbeau | PSU | 2025-08-07 | 17,500 | 35,000 | — | 70,000 | $128,800 |
| Michelle Barbeau | RSU | 2025-04-09 | — | — | 35,000 | — | 224,350 |
| Derrick Duke | RSU | 2025-08-04 | — | — | 300,000 | — | 978,000 |
| John Dolan | RSU | 2025-04-09 | — | — | 35,000 | — | 224,350 |
| John Dolan | PSU | 2025-08-07 | 17,500 | 35,000 | — | 70,000 | 128,800 |
| Derrick Duke | PSU | 2025-08-04 | 150,000 | 300,000 | — | 600,000 | 978,000 |
Vehicle mix — grant-date fair value by award type
| Named executive officer | Time-vested (RSU) | Performance-vested (PSU) | Options / SARs | % performance-vested |
|---|---|---|---|---|
| Michelle Barbeau | $224,350 | $128,800 | $0 | 36.5% |
| Derrick Duke | 978,000 | 978,000 | 0 | 50.0% |
| John Dolan | 224,350 | 128,800 | 0 | 36.5% |
% performance-vested = PSU grant-date fair value ÷ (RSU + PSU + Options), a computed value with the derivation shown in the register.
Outstanding equity awards at fiscal year-end 2025
| Executive | Award | Shares unvested | Exercise price | Market value unvested |
|---|---|---|---|---|
| Michelle Barbeau | RSU | 6,329 | — | $29,113 |
| John Dolan | RSU | 7,735 | — | 35,581 |
| John Dolan | RSU | 8,318 | — | 38,263 |
| John Dolan | RSU | 13,000 | — | 59,800 |
| John Dolan | RSU | 15,650 | — | 71,990 |
| Michelle Barbeau | RSU | 15,650 | — | 71,990 |
| John Dolan | PSU | 21,000 | — | 96,600 |
| Michelle Barbeau | RSU | 28,196 | — | 129,702 |
| John Dolan | RSU | 32,500 | — | 149,500 |
| John Dolan | RSU | 35,000 | — | 161,000 |
| John Dolan | PSU | 35,000 | — | 161,000 |
| Michelle Barbeau | RSU | 35,000 | — | 161,000 |
| Michelle Barbeau | PSU | 35,000 | — | 161,000 |
| Michelle Barbeau | RSU | 37,500 | — | 172,500 |
| John Dolan | PSU | 52,500 | — | 241,500 |
| Michelle Barbeau | PSU | 70,000 | — | 322,000 |
| Francis Soistman | RSU | 83,333 | — | 383,332 |
| Francis Soistman | PSU | 250,000 | — | 1,150,000 |
| Derrick Duke | PSU | 300,000 | — | 1,380,000 |
| Derrick Duke | RSU | 300,000 | — | 1,380,000 |
Director compensation
| Director | Cash fees | Stock awards | Option awards | Non-equity incentive | All other | Total |
|---|---|---|---|---|---|---|
| Beth A. BrookeIndependent · Board Chair · Audit · Nominating and Corporate Governance · Financing Committee | $152,500 | $140,370 | $0 | $0 | $0 | $292,870 |
| Erin L. RussellIndependent · Audit (Chair) · Compensation · Financing Committee · Strategy Committee | 120,000 | 140,370 | 0 | 0 | 0 | 260,370 |
| A. John Hass, IIIIndependent · Audit · Government and Regulatory Affairs (Chair) | 107,500 | 140,370 | 0 | 0 | 0 | 247,870 |
| Andrea C. BrimmerIndependent · Compensation (Chair) · Nominating and Corporate Governance · Equity Incentive Committee (Chair) · Not standing for re-election | 107,500 | 140,370 | 0 | 0 | 0 | 247,870 |
| Dale B. WolfIndependent · Nominating and Corporate Governance (Chair) · Compensation · Audit · Financing Committee | 105,000 | 140,370 | 0 | 0 | 0 | 245,370 |
| Prama BhattIndependent · Audit · Government and Regulatory Affairs | 102,500 | 140,370 | 0 | 0 | 0 | 242,870 |
| Cesar M. SorianoIndependent · Compensation · Government and Regulatory Affairs | 100,000 | 140,370 | 0 | 0 | 0 | 240,370 |
| Todd ArdenIndependent · Compensation · Nominating and Corporate Governance · Government and Regulatory Affairs · Strategy Committee · Financing Committee · Partial-year service · Newly elected | 33,571 | 148,579 | 0 | 0 | 0 | 182,150 |
| Francis S. SoistmanIndependent · Nominating and Corporate Governance · Government and Regulatory Affairs · Financing Committee · Strategy Committee | 0 | 0 | 0 | 0 | 0 | 0 |
| Derrick A. DukeEmployee director · Equity Incentive Committee · Strategy Committee (Chair) · Partial-year service · Newly elected | 0 | 0 | 0 | — | 0 | 0 |
| Aaron C. TolsonIndependent · Departed during FY | 0 | 0 | 0 | 0 | 0 | 0 |
Board fee structure and ownership guideline
| Annual cash retainer | $62,500 |
|---|---|
| Annual equity retainer | — |
| Per board meeting fee | — |
| Committee chair fees (audit / comp / nom-gov) | 12,500 / 7,500 / 5,000 |
| Stock ownership guideline | 5x annual cash retainer |
Total cost of the board
| Component | FY2025 |
|---|---|
| Cash retainers and fees | $828,571 |
| Equity awards (grant-date value) | $1,131,169 |
| All other compensation | $0 |
| Total cost of the board | $1,959,740 |
Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.
Peer group, and who names eHealth as a peer
Companies that benchmark against EHTH
4 companies name EHTH as a compensation peer
- CLOVER HEALTH INVESTMENTS, CORP. /DECLOVFY2025
- Hippo Holdings Inc.HIPOFY2025
- SelectQuote, Inc.SLQTFY2025
- TrueCar, Inc.TRUEFY2025
Each company listed discloses EHTH in its own benchmarking peer group, as disclosed in each company's most recent proxy statement within the last two proxy seasons. Two companies are therefore absent by design: one that named EHTH in an earlier year and no longer does, and one whose own most recent disclosure is older than the last two seasons.
Disclosed peer group — fiscal year 2025
The compensation peer group as the company disclosed it in its own proxy — the reference set behind the percentile above.
PHR Phreesia, Inc.QUOT Quotient Technology, Inc.HIPO Hippo Holdings, Inc.HR NextGen Healthcare, Inc.CTEV Claritev CorporationALHC Alignment Healthcare, Inc.PRTH Priority Technology Holdings, Inc.AIG American Well CorporationGOCO GoHealth, Inc. Vericity, Inc.GSHD Goosehead Insurance, Inc.OSCR Oscar Health, Inc.ACCD Accolade, Inc.SLQT SelectQuote, Inc.SHCR Sharecare, Inc.TBRG Trubridge, Inc.EVER EverQuote, Inc.CRD-B Crawford & CompanyCLOV Clover Health Investments GroupTRHC Tabula Rasa HealthCare, Inc.MAX MediaAlpha, Inc.BWIN The Baldwin Insurance GroupHCAT Health Catalyst, Inc.
Peer reciprocity
Of the companies eHealth, Inc. names as compensation peers, which name it back in their own disclosed peer groups. A peer set the market reciprocates reads differently from one selected in a single direction.
— Phreesia, Inc. (PHR)77— Quotient Technology, Inc. (QUOT)78 Hippo Holdings, Inc. (HIPO)— NextGen Healthcare, Inc. (HR)79— Claritev Corporation (CTEV)80— Alignment Healthcare, Inc. (ALHC)81 Priority Technology Holdings, Inc. (PRTH)— American Well Corporation (AIG)82 GoHealth, Inc. (GOCO)— Goosehead Insurance, Inc. (GSHD)83— Oscar Health, Inc. (OSCR)84— Accolade, Inc. (ACCD)85✓ SelectQuote, Inc. (SLQT)86— Sharecare, Inc. (SHCR)87— Trubridge, Inc. (TBRG)88 EverQuote, Inc. (EVER)— Crawford & Company (CRD-B)89✓ Clover Health Investments Group (CLOV)90✓ Tabula Rasa HealthCare, Inc. (TRHC)91— MediaAlpha, Inc. (MAX)92— The Baldwin Insurance Group (BWIN)93— Health Catalyst, Inc. (HCAT)94
Reciprocity shown where the peer’s own current proxy has been read — each mark is cited in the register to that peer’s filing. A dash means the peer’s current proxy was read and names no reciprocal group including eHealth, Inc..
Chief executive pay against the peer group
Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company’s own proxy statement.
| Rank | Company | FY | Chief executive | Salary | Stock awards | Option awards | Non-equity incentive | Total |
|---|---|---|---|---|---|---|---|---|
| 1 | American Well Corporation | 2025 | Peter Zaffino | $1,500,000 | $14,084,855 | $4,374,994 | $12,000,000 | $32,460,049 |
| 2 | GoHealth, Inc. | 2025 | Vijay Kotte | 969,231 | 10,734,997 | 0 | 0 | 13,757,255 |
| 3 | NextGen Healthcare, Inc. | 2025 | Peter Scott | 534,091 | 10,336,831 | 0 | 1,984,500 | 12,855,422 |
| 4 | Alignment Healthcare, Inc. | 2025 | John Kao | 833,654 | 8,500,014 | 0 | 1,944,495 | 11,278,583 |
| 5 | Claritev Corporation | 2025 | Travis Dalton | 825,000 | 8,234,542 | 0 | 1,134,375 | 10,202,667 |
| 6 | EverQuote, Inc. | 2025 | Jayme Mendal | 595,000 | 7,781,866 | 0 | 818,125 | 9,209,231 |
| 7 | Phreesia, Inc. | 2026 | Chaim Indig | 515,000 | 7,562,706 | 0 | 0 | 8,077,706 |
| 8 | Priority Technology Holdings, Inc. | 2025 | Thomas Priore | 1,200,000 | 2,996,498 | 0 | 0 | 8,004,152 |
| 9 | MediaAlpha, Inc. | 2025 | Steven Yi | 591,667 | 5,643,240 | 0 | 740,534 | 7,037,094 |
| 10 | Hippo Holdings, Inc. | 2025 | Richard McCathron | 660,000 | 4,767,265 | 0 | 495,000 | 5,997,265 |
| 11 | The Baldwin Insurance Group | 2025 | Trevor Baldwin | 400,000 | 3,068,032 | 0 | 1,785,000 | 5,253,032 |
| 12 | Goosehead Insurance, Inc. | 2025 | Mark K. Miller | 750,000 | 0 | 3,682,400 | 0 | 4,850,272 |
| 13 | Quotient Technology, Inc. | 2022 | Matthew Krepsik | 450,521 | 2,901,801 | 1,227,480 | 0 | 4,585,802 |
| 14 | Health Catalyst, Inc. | 2025 | Daniel Burton | 525,000 | 3,444,040 | 0 | 0 | 3,991,159 |
| 15 | Accolade, Inc. | 2024 | Rajeev Singh | 500,000 | 3,320,097 | 0 | 0 | 3,823,597 |
| 16 | eHealth, Inc. | 2025 | Derrick Duke | 290,769 | 1,956,000 | 0 | 414,247 | 3,262,665 |
| 17 | SelectQuote, Inc. | 2026 | Timothy Danker | 650,000 | 1,595,200 | 0 | 636,589 | 2,899,920 |
| 18 | Trubridge, Inc. | 2024 | Christopher L. Fowler | 618,000 | 1,292,621 | 0 | 451,140 | 2,363,761 |
| 19 | Tabula Rasa HealthCare, Inc. | 2022 | Brian Adams | 450,000 | 1,633,498 | 0 | 190,688 | 2,301,712 |
| 20 | Crawford & Company | 2025 | Rohit Verma | 805,000 | 479,159 | 0 | 0 | 1,394,129 |
| 21 | Clover Health Investments Group | 2025 | Andrew Toy | 800,000 | 0 | 0 | 509,539 | 1,319,385 |
| 22 | Oscar Health, Inc. | 2025 | Mark Bertolini | 619,178 | 0 | 0 | 169,036 | 1,149,308 |
| — | Sharecare, Inc. | — | — | — | — | — | — | not in coverage universe |
Each peer’s compensation is from its most recently filed proxy; fiscal years differ by company. Each peer’s figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.
Incentive design against the same peers
| Company | Annual incentive payout | Long-term vehicle mix | PSU measures include TSR | Compensation consultant |
|---|---|---|---|---|
| eHealth, Inc. | not disclosed | PSU 50 · RSU 50 | No | Aon |
| Accolade, Inc. | not disclosed | PSU 50 · RSU 50 | No | FW Cook |
| Alignment Healthcare, Inc. | 200% | not disclosed | No | FW Cook |
| American Well Corporation | not disclosed | PSU 75 · Options 25 | No | Pay Governance |
| Claritev Corporation | 110% | Cash LTI 75 · RSU 25 | not disclosed | Korn Ferry |
| Clover Health Investments Group | 64% | RSU 60 · Cash LTI 40 | No | Aon, plc (Human Capital Practice) |
| Crawford & Company | not disclosed | RSU 50 · Cash LTI 50 | No | Pay Governance LLC |
| EverQuote, Inc. | 137.5% | PSU 50 · RSU 50 | No | Compensia, Inc. |
| GoHealth, Inc. | 50% | RSU 100 | not disclosed | Pearl Meyer and Partners, LLC |
| Goosehead Insurance, Inc. | not disclosed | Option 100 | not disclosed | Semler |
| Health Catalyst, Inc. | 39% | RSU 50 · PRSU 50 | Yes — TSR Achievement | Aon |
| Hippo Holdings, Inc. | not disclosed | not disclosed | Yes — TSR performance compared to HSCM Insurtech Index | not disclosed |
| MediaAlpha, Inc. | 123.4% | RSU 100 | not disclosed | ClearBridge |
| NextGen Healthcare, Inc. | not disclosed | PSU 60 · RSU 40 | Yes — Relative TSR compared to the TSR peer group | Ferguson Partners |
| Oscar Health, Inc. | 91.0% | RSU 50 · PSU 50 | Yes — Relative TSR | FW Cook |
| Phreesia, Inc. | 140.3% | PSU 50 · RSU 50 | Yes — Relative TSR | FW Cook, Inc. |
| Priority Technology Holdings, Inc. | not disclosed | not disclosed | No | not disclosed |
| Quotient Technology, Inc. | not disclosed | RSU 50 · PSU 50 | No | Aon |
| SelectQuote, Inc. | 126% | not disclosed | No | Semler Brossy |
| Sharecare, Inc. | 47% | RSU 75 · PSU 25 | No | not disclosed |
| Tabula Rasa HealthCare, Inc. | not disclosed | PSU 50 · RSU 50 | not disclosed | Pearl Meyer & Partners, LLC |
| The Baldwin Insurance Group | 111.6% | PSU 100 | Yes — Relative TSR v. Compensation Peer Group | Frederic W. Cook & Co., Inc. |
| Trubridge, Inc. | 100% | PSU 60 · RSU 40 | No | Frederic W. Cook & Co., Inc. |
Read from each company’s Compensation Discussion and Analysis: annual incentive payout as a percentage of target, the disclosed long-term vehicle mix, whether performance-share measures include a total shareholder return component, and the retained compensation consultant. “Not disclosed” appears only where the company’s filing does not state the item.
Say-on-pay history and pay ratio
| Meeting year | Meeting date | For | Against | Abstain | Support | Outcome |
|---|---|---|---|---|---|---|
| 2026 | 2026-06-25 | 18,199,238 | 1,375,703 | 1,626,440 | 92.97% | Passed |
| 2025 | 2025-06-18 | 16,247,390 | 2,280,482 | 7,536 | 87.69% | Passed |
| 2024 | 2024-06-14 | 17,329,691 | 3,668,180 | 25,369 | 82.53% | Passed |
| 2023 | 2023-06-14 | 15,739,487 | 4,874,189 | 24,623 | 76.35% | Passed |
| 2022 | 2022-06-15 | 17,104,867 | 4,713,929 | 818,135 | 78.4% | Passed |
| 2021 | 2021-06-30 | 19,644,918 | 3,374,656 | 15,037 | 85.34% | Passed |
Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year’s compensation.
Say-on-pay — history, company’s computation
| Meeting year | Meeting date | Approval — company’s computation |
|---|---|---|
| 2026 | 2026-06-25 | 92.97%a |
| 2025 | 2025-06-18 | 87.69%b |
| 2024 | 2024-06-14 | 82.53%c |
a. Approved under the standard stated in the filing — “Abstentions or withhold votes, as applicable, will have no effect on the outcome of the vote on these proposals, although abstentions and withhold votes are considered for the purpose of determining the presence of a quorum.”.
b. Approved under the standard stated in the filing — “Abstentions or withhold votes, as applicable, will have no effect on the outcome of the vote on these proposals, although abstentions and withhold votes are considered for the purpose of determining the presence of a quorum.”.
c. Approved under the standard stated in the filing — “Abstentions will have no effect on the outcome of the vote on these proposals, although abstentions are considered for the purpose of determining the presence of a quorum.”.
Approval percentages are the company’s own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.
CEO pay ratio
| Ratio (CEO : median employee) | — |
|---|---|
| CEO total compensation | — |
| Median employee compensation | — |
Insider trades since the proxy
Every insider equity transaction reported on Form 4 after the 2025 proxy statement — acquisitions, dispositions, exercises, and withholdings — and therefore not reflected in any table in that document.
| Insider | Role | Transaction date | Code | Shares | Price | Value | Security | Source |
|---|---|---|---|---|---|---|---|---|
| John Dolan | Chief Financial Officer | 2026-05-10 | D | 1,500 | $2 | $2,835 | Common | Form 4 ↗ |
| Gavin G. Galimi | SVP, General Counsel & Secr. | 2026-06-10 | D | 1,782 | 2 | 2,922 | Common | Form 4 ↗ |
| Michelle Barbeau | Chief Revenue Officer | 2026-06-10 | D | 4,311 | 2 | 7,070 | Common | Form 4 ↗ |
| Todd Arden | Director | 2026-06-18 | A | 61,041 | 0 | 0 | Common | Form 4 ↗ |
| A. John Hass, III | Director | 2026-06-18 | A | 61,041 | 0 | 0 | Common | Form 4 ↗ |
| Beth A. Brooke | Director | 2026-06-18 | A | 61,041 | 0 | 0 | Common | Form 4 ↗ |
| Erin L. Russell | Director | 2026-06-18 | A | 61,041 | 0 | 0 | Common | Form 4 ↗ |
| Francis S. Soistman Jr | Director | 2026-06-18 | A | 61,041 | 0 | 0 | Common | Form 4 ↗ |
| Prama Bhatt | Director | 2026-06-18 | A | 61,041 | 0 | 0 | Common | Form 4 ↗ |
| Dale B. Wolf | Director | 2026-06-18 | A | 61,041 | 0 | 0 | Common | Form 4 ↗ |
| Michelle Barbeau | Chief Revenue Officer | 2026-07-10 | D | 323 | 2 | 523 | Common | Form 4 ↗ |
| Gavin G. Galimi | SVP, General Counsel & Secr. | 2026-07-10 | D | 841 | 2 | 1,362 | Common | Form 4 ↗ |
| John Dolan | Chief Financial Officer | 2026-07-10 | D | 465 | 2 | 753 | Common | Form 4 ↗ |
| Derrick A. Duke | Director | 2026-08-04 | D | 24,350 | 1 | 34,577 | Common | Form 4 ↗ |
| Francis S. Soistman Jr | Director | 2026-08-31 | D | 37,296 | 1 | 42,432 | Common | Form 4 ↗ |
| Gavin G. Galimi | SVP, General Counsel & Secr. | 2026-09-01 | A | 60,000 | 0 | 0 | Common | Form 4 ↗ |
| John Dolan | Chief Financial Officer | 2026-09-01 | A | 70,000 | 0 | 0 | Common | Form 4 ↗ |
| Michelle Barbeau | Chief Revenue Officer | 2026-09-01 | A | 70,000 | 0 | 0 | Common | Form 4 ↗ |
| Francis S. Soistman Jr | Director | 2026-09-01 | D | 37,297 | 1 | 39,277 | Common | Form 4 ↗ |
| John Dolan | Chief Financial Officer | 2026-09-10 | D | 5,859 | 1 | 5,390 | Common | Form 4 ↗ |
| Michelle Barbeau | Chief Revenue Officer | 2026-09-10 | D | 4,312 | 1 | 3,967 | Common | Form 4 ↗ |
| Francis S. Soistman Jr | Director | 2026-10-01 | D | 20,306 | 1 | 14,137 | Common | Form 4 ↗ |
| Francis S. Soistman Jr | Director | 2026-10-02 | D | 20,306 | 1 | 14,038 | Common | Form 4 ↗ |
| Michelle Barbeau | Chief Revenue Officer | 2026-10-10 | D | 323 | 1 | 226 | Common | Form 4 ↗ |
| John Dolan | Chief Financial Officer | 2026-10-10 | D | 465 | 1 | 326 | Common | Form 4 ↗ |
| Gavin G. Galimi | SVP, General Counsel & Secr. | 2026-10-10 | D | 842 | 1 | 589 | Common | Form 4 ↗ |
Transaction codes per Form 4: A acquisition · S open-market sale · F tax withholding · M option exercise · G gift. Value = shares × price as reported. Dividend-equivalent and fractional-share accrual rows (derivative Class A, under $10,000 and under 2,000 shares) are aggregated per date; every row appears in full below.
Sources (94 citations)
Each figure is listed with the filing it comes from, where it appears in that filing, and the value as printed. Any figure can be independently confirmed against the source.
- Section 01, Derrick Duke. DEF 14A, filed 2026-04-28. Section “2025 Summary Compensation Table” · page 52. As printed: 3,262,665. View filing ↗
- Section 01, Francis Soistman. DEF 14A, filed 2026-04-28. Section “2025 Summary Compensation Table”. As printed: 2,845,179. View filing ↗
- Section 01, John Dolan. DEF 14A, filed 2026-04-28. Section “2025 Summary Compensation Table”. As printed: 1,228,724. View filing ↗
- Section 01, Michelle Barbeau. DEF 14A, filed 2026-04-28. Section “2025 Summary Compensation Table”. As printed: 1,183,167. View filing ↗
- Section 03, Michelle Barbeau PSU. DEF 14A, filed 2026-04-28. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, Michelle Barbeau RSU. DEF 14A, filed 2026-04-28. Section “2025 Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, Derrick Duke RSU. DEF 14A, filed 2026-04-28. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, John Dolan RSU. DEF 14A, filed 2026-04-28. Section “2025 Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, John Dolan PSU. DEF 14A, filed 2026-04-28. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, Derrick Duke PSU. DEF 14A, filed 2026-04-28. Section “2025 Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 07, pay ratio. 10-K, filed 2026-02-26. Section “CEO Pay Ratio”. As printed: —. View filing ↗
- Section 08, Beth A. Brooke. DEF 14A, filed 2026-04-28. Section “Director Compensation”. As printed: 292,870. View filing ↗
- Section 08, Erin L. Russell. DEF 14A, filed 2026-04-28. Section “Director Compensation”. As printed: 260,370. View filing ↗
- Section 08, A. John Hass, III. DEF 14A, filed 2026-04-28. Section “Director Compensation”. As printed: 247,870. View filing ↗
- Section 08, Andrea C. Brimmer. DEF 14A, filed 2026-04-28. Section “Director Compensation”. As printed: 247,870. View filing ↗
- Section 08, Dale B. Wolf. DEF 14A, filed 2026-04-28. Section “Director Compensation”. As printed: 245,370. View filing ↗
- Section 08, Prama Bhatt. DEF 14A, filed 2026-04-28. Section “Director Compensation”. As printed: 242,870. View filing ↗
- Section 08, Cesar M. Soriano. DEF 14A, filed 2026-04-28. Section “Director Compensation”. As printed: 240,370. View filing ↗
- Section 08, Todd Arden. DEF 14A, filed 2026-04-28. Section “Director Compensation”. As printed: 182,150. View filing ↗
- Section 08, Francis S. Soistman. DEF 14A, filed 2026-04-28. Section “Director Compensation”. As printed: 0. View filing ↗
- Section 08, Derrick A. Duke. DEF 14A, filed 2026-04-28. Section “Director Compensation”. As printed: 0. View filing ↗
- Section 08, Aaron C. Tolson. DEF 14A, filed 2026-04-28. Section “Director Compensation”. As printed: 0. View filing ↗
- Section 02, John Dolan 2026-05-10. Form 4, filed 2026-05-12. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Gavin G. Galimi 2026-06-10. Form 4, filed 2026-06-12. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Michelle Barbeau 2026-06-10. Form 4, filed 2026-06-12. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Todd Arden 2026-06-18. Form 4, filed 2026-06-23. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, A. John Hass, III 2026-06-18. Form 4, filed 2026-06-23. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Beth A. Brooke 2026-06-18. Form 4, filed 2026-06-23. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Erin L. Russell 2026-06-18. Form 4, filed 2026-06-23. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Francis S. Soistman Jr 2026-06-18. Form 4, filed 2026-06-23. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Prama Bhatt 2026-06-18. Form 4, filed 2026-06-23. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Dale B. Wolf 2026-06-18. Form 4, filed 2026-06-23. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Michelle Barbeau 2026-07-10. Form 4, filed 2026-07-14. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Gavin G. Galimi 2026-07-10. Form 4, filed 2026-07-14. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, John Dolan 2026-07-10. Form 4, filed 2026-07-14. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Derrick A. Duke 2026-08-04. Form 4, filed 2026-08-05. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Francis S. Soistman Jr 2026-08-31. Form 4, filed 2026-09-02. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Gavin G. Galimi 2026-09-01. Form 4, filed 2026-09-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, John Dolan 2026-09-01. Form 4, filed 2026-09-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Michelle Barbeau 2026-09-01. Form 4, filed 2026-09-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Francis S. Soistman Jr 2026-09-01. Form 4, filed 2026-09-02. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, John Dolan 2026-09-10. Form 4, filed 2026-09-11. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Michelle Barbeau 2026-09-10. Form 4, filed 2026-09-11. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Francis S. Soistman Jr 2026-10-01. Form 4, filed 2026-10-02. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Francis S. Soistman Jr 2026-10-02. Form 4, filed 2026-10-02. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Michelle Barbeau 2026-10-10. Form 4, filed 2026-10-13. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, John Dolan 2026-10-10. Form 4, filed 2026-10-13. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Gavin G. Galimi 2026-10-10. Form 4, filed 2026-10-13. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 06, 2026 vote. Form 8-K, filed 2026-06-25. Item 5.07 · say-on-pay result. As reported: 92.97% (votes for as printed: 18,199,238). View filing ↗
- Section 06, 2025 vote. Form 8-K, filed 2025-06-24. Item 5.07 · say-on-pay result. As reported: 87.69% (votes for as printed: 16,247,390). View filing ↗
- Section 06, 2024 vote. Form 8-K, filed 2024-06-14. Item 5.07 · say-on-pay result. As reported: 82.53% (votes for as printed: 17,329,691). View filing ↗
- Section 01 trend, Δ column (computed). Computed. Δ = current-FY total − prior-FY total per named officer.
- Section 03b vehicle mix (computed). Computed. RSU / PSU / Options grant-date fair values summed per officer from the grants table; % performance-vested = PSU ÷ (RSU+PSU+Options).
- Section 09b board cost (computed). Computed. Cash 828,571 + equity 1,131,169 + all other 0 = 1,959,740, summed across the director compensation table rows.
- American Well Corporation, Section 10b CEO total. DEF 14A, filed 2026-03-31. CEO total compensation as printed in American Well Corporation's own proxy. As printed: 32,460,049. View filing ↗
- GoHealth, Inc., Section 10b CEO total. DEF 14A, filed 2026-04-30. CEO total compensation as printed in GoHealth, Inc.'s own proxy. As printed: 13,757,255. View filing ↗
- NextGen Healthcare, Inc., Section 10b CEO total. DEF 14A, filed 2026-04-07. CEO total compensation as printed in NextGen Healthcare, Inc.'s own proxy. As printed: 12,855,422. View filing ↗
- Alignment Healthcare, Inc., Section 10b CEO total. DEF 14A, filed 2026-04-24. CEO total compensation as printed in Alignment Healthcare, Inc.'s own proxy. As printed: 11,278,583. View filing ↗
- Claritev Corporation, Section 10b CEO total. DEF 14A, filed 2026-03-20. CEO total compensation as printed in Claritev Corporation's own proxy. As printed: 10,202,667. View filing ↗
- EverQuote, Inc., Section 10b CEO total. DEF 14A, filed 2026-04-23. CEO total compensation as printed in EverQuote, Inc.'s own proxy. As printed: 9,209,231. View filing ↗
- Phreesia, Inc., Section 10b CEO total. DEF 14A, filed 2026-05-14. CEO total compensation as printed in Phreesia, Inc.'s own proxy. As printed: 8,077,706. View filing ↗
- Priority Technology Holdings, Inc., Section 10b CEO total. DEF 14A, filed 2026-04-28. CEO total compensation as printed in Priority Technology Holdings, Inc.'s own proxy. As printed: 8,004,152. View filing ↗
- MediaAlpha, Inc., Section 10b CEO total. DEF 14A, filed 2026-03-23. CEO total compensation as printed in MediaAlpha, Inc.'s own proxy. As printed: 7,037,094. View filing ↗
- Hippo Holdings, Inc., Section 10b CEO total. DEF 14A, filed 2026-04-22. CEO total compensation as printed in Hippo Holdings, Inc.'s own proxy. As printed: 5,997,265. View filing ↗
- The Baldwin Insurance Group, Section 10b CEO total. DEF 14A, filed 2026-04-22. CEO total compensation as printed in The Baldwin Insurance Group's own proxy. As printed: 5,253,032. View filing ↗
- Goosehead Insurance, Inc., Section 10b CEO total. DEF 14A, filed 2026-03-25. CEO total compensation as printed in Goosehead Insurance, Inc.'s own proxy. As printed: 4,850,272. View filing ↗
- Quotient Technology, Inc., Section 10b CEO total. DEF 14A, filed 2023-06-30. CEO total compensation as printed in Quotient Technology, Inc.'s own proxy. As printed: 4,585,802. View filing ↗
- Health Catalyst, Inc., Section 10b CEO total. DEF 14A, filed 2026-06-03. CEO total compensation as printed in Health Catalyst, Inc.'s own proxy. As printed: 3,991,159. View filing ↗
- Accolade, Inc., Section 10b CEO total. DEF 14A, filed 2024-06-21. CEO total compensation as printed in Accolade, Inc.'s own proxy. As printed: 3,823,597. View filing ↗
- eHealth, Inc. (subject), Section 10b CEO total. DEF 14A, filed 2026-04-28. CEO total compensation as printed in eHealth, Inc.'s own proxy. As printed: 3,262,665. View filing ↗
- SelectQuote, Inc., Section 10b CEO total. DEF 14A, filed 2026-09-30. CEO total compensation as printed in SelectQuote, Inc.'s own proxy. As printed: 2,899,920. View filing ↗
- Trubridge, Inc., Section 10b CEO total. DEF 14A, filed 2025-03-26. CEO total compensation as printed in Trubridge, Inc.'s own proxy. As printed: 2,363,761. View filing ↗
- Tabula Rasa HealthCare, Inc., Section 10b CEO total. DEF 14A, filed 2023-04-28. CEO total compensation as printed in Tabula Rasa HealthCare, Inc.'s own proxy. As printed: 2,301,712. View filing ↗
- Crawford & Company, Section 10b CEO total. DEF 14A, filed 2026-04-09. CEO total compensation as printed in Crawford & Company's own proxy. As printed: 1,394,129. View filing ↗
- Clover Health Investments Group, Section 10b CEO total. DEF 14A, filed 2026-04-28. CEO total compensation as printed in Clover Health Investments Group's own proxy. As printed: 1,319,385. View filing ↗
- Oscar Health, Inc., Section 10b CEO total. DEF 14A, filed 2026-04-22. CEO total compensation as printed in Oscar Health, Inc.'s own proxy. As printed: 1,149,308. View filing ↗
- Section 10a, Phreesia, Inc. reciprocity. DEF 14A. Phreesia, Inc.'s most recent proxy was read; its disclosed peer group does not include eHealth, Inc.. View filing ↗
- Section 10a, Quotient Technology, Inc. reciprocity. DEF 14A. Quotient Technology, Inc.'s most recent proxy was read; its disclosed peer group does not include eHealth, Inc.. View filing ↗
- Section 10a, NextGen Healthcare, Inc. reciprocity. DEF 14A. NextGen Healthcare, Inc.'s most recent proxy was read; its disclosed peer group does not include eHealth, Inc.. View filing ↗
- Section 10a, Claritev Corporation reciprocity. DEF 14A. Claritev Corporation's most recent proxy was read; its disclosed peer group does not include eHealth, Inc.. View filing ↗
- Section 10a, Alignment Healthcare, Inc. reciprocity. DEF 14A. Alignment Healthcare, Inc.'s most recent proxy was read; its disclosed peer group does not include eHealth, Inc.. View filing ↗
- Section 10a, American Well Corporation reciprocity. DEF 14A. American Well Corporation's most recent proxy was read; its disclosed peer group does not include eHealth, Inc.. View filing ↗
- Section 10a, Goosehead Insurance, Inc. reciprocity. DEF 14A. Goosehead Insurance, Inc.'s most recent proxy was read; its disclosed peer group does not include eHealth, Inc.. View filing ↗
- Section 10a, Oscar Health, Inc. reciprocity. DEF 14A. Oscar Health, Inc.'s most recent proxy was read; its disclosed peer group does not include eHealth, Inc.. View filing ↗
- Section 10a, Accolade, Inc. reciprocity. DEF 14A. Accolade, Inc.'s most recent proxy was read; its disclosed peer group does not include eHealth, Inc.. View filing ↗
- Section 10a, SelectQuote, Inc. reciprocity. DEF 14A. SelectQuote, Inc. names eHealth, Inc. in its own disclosed peer group (read from its most recent proxy). View filing ↗
- Section 10a, Sharecare, Inc. reciprocity. DEF 14A. Sharecare, Inc.'s most recent proxy was read; its disclosed peer group does not include eHealth, Inc.. View filing ↗
- Section 10a, Trubridge, Inc. reciprocity. DEF 14A. Trubridge, Inc.'s most recent proxy was read; its disclosed peer group does not include eHealth, Inc.. View filing ↗
- Section 10a, Crawford & Company reciprocity. DEF 14A. Crawford & Company's most recent proxy was read; its disclosed peer group does not include eHealth, Inc.. View filing ↗
- Section 10a, Clover Health Investments Group reciprocity. DEF 14A. Clover Health Investments Group names eHealth, Inc. in its own disclosed peer group (read from its most recent proxy). View filing ↗
- Section 10a, Tabula Rasa HealthCare, Inc. reciprocity. DEF 14A. Tabula Rasa HealthCare, Inc. names eHealth, Inc. in its own disclosed peer group (read from its most recent proxy). View filing ↗
- Section 10a, MediaAlpha, Inc. reciprocity. DEF 14A. MediaAlpha, Inc.'s most recent proxy was read; its disclosed peer group does not include eHealth, Inc.. View filing ↗
- Section 10a, The Baldwin Insurance Group reciprocity. DEF 14A. The Baldwin Insurance Group's most recent proxy was read; its disclosed peer group does not include eHealth, Inc.. View filing ↗
- Section 10a, Health Catalyst, Inc. reciprocity. DEF 14A. Health Catalyst, Inc.'s most recent proxy was read; its disclosed peer group does not include eHealth, Inc.. View filing ↗